1. Dzau VJ, Colucci WS, Williams GH, Curfman G, Meggs L, Hollenberg NK. Sustained effectiveness of converting enzyme inhibition in patients moribund with congestive heart failure. N Engl J Med 1980; 302:1373-1378.

2. Colucci WS, Wynne J, Holman BL, Braunwald E. Long-term therapy of heart failure with prazosin: a randomized double-blind trial. Am J Cardiol 1980; 45:337-344.

3. Colucci WS, Williams GH, Braunwald E. Increased plasma norepinephrine during prazosin therapy of severe congestive heart failure. Ann Intern Med 1980; 93:452-453.

4. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981; 63:645-651.

5. Colucci WS, Holman BL, Wynne J, Carabello B, Malacoff R, Grossman W, Braunwald E. Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure. Am J Med 1981; 71:75-80.

6. Rude RE, Turi Z, Brown EJ, Lorell BH, Colucci WS, Mudge GH Jr, Taylor CR, Grossman W. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure. Circulation 1981; 64:139-145.

7. Colucci WS, Alexander RW, Williams GH Rude RE, Holman BL, Konstam MA, Wynne J, Mudge GH Jr, Braunwald E. Decreased lymphocyte beta-adrenergic receptor density in heart failure patients tolerant to the beta-adrenergic agonist pirbuterol. N Engl J Med 1981; 305:185-190.

8. Colucci WS, Lorell BH, Schoen FJ, Warhol MJ, Grossman W. Hypertrophic obstructive cardiomyopathy due to Fabry's disease. N Engl J Med 1982; 307:926-928.

9. Polak JF, Holman BL, Wynne J, Colucci WS. Right ventricular ejection fraction: An indicator of increased mortality in congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 1983; 2:217-224.

10. Ganz P, Gaspar J, Colucci WS, Barry WH, Mudge GH, Alexander RW. Effects of prostacyclin on coronary hemodynamics in patients with coronary artery disease. Am J Cardiol 1984; 53:1500-1504.

11. Monrad ES, McKay RG, Baim DS, Colucci WS, Fifer MA, Heller GV, Royal HD, Grossman W. Improvement in indices of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation 1984; 70:1030-1037.

12. Colucci WS, Jaski BE, Fifer MA, Wright RF, Braunwald E. Milrinone: A positive inotropic vasodilator. Trans Am Assoc Phys 1984; XCVII:124-133.

13. Kern MJ, Horowitz JD, Ganz P, Gaspar J, Colucci WS, Lorell BH, Barry WH, Mudge GH. Selective alpha-1 adrenergic mediated coronary vasoconstriction in patients with coronary artery disease. J Am Coll Cardiol 1985; 5:840-846.

14. Fifer MA, Colucci WS, Lorell BH, Jaski BE, Barry WH. Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: Comparison with nitroprusside. J Am Coll Cardiol 1985; 5:731-737.

15. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure: Dose-response relationships to nitroprusside. J Clin Invest 1985; 75:643-649.

16. Colucci WS, Brock TA, Gimbrone MA Jr, Alexander RW. Nonlinear relationship between alpha-1 receptor occupancy and norepinephrine-stimulated calcium flux in cultured vascular smooth muscle cells. Mol Pharmacol 1985; 27:517-524.

17. White HD, Ribeiro JP, Hartley LH, Colucci WS. Immediate effects of milrinone on metabolic and sympathetic responses to exercises in severe congestive heart failure. Am J Cardiol 1985; 56:93-98.

18. Ludmer PL, Wright RF, Arnold JMO, Ganz P, Braunwald E, Colucci WS. Separation of the direct myocardial and vasodilator actions of milrinone: Studies utilizing an intracoronary infusion technique. Circulation 1985; 73:130-137.

19. Colucci WS, Ludmer PL, Arnold JMO, Wright RF, Ganz P, Braunwald E. Myocardial and vascular actions of intracoronary versus intravenous milrinone. Trans Am Assoc Phys 1986; XCVIII:136-145.

20. Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E. Milrinone and dobutamine in severe congestive heart failure: Differing hemodynamic effects and individual patient responsiveness. Circulation 1986; 73 (Suppl III):III-175-III-183.

21. Baim DS, Colucci WS, Monrad ES, Smith HS, Wright RF, Lanoue A, Gauthier DF, Ransil BJ, Grossman W, Braunwald E. Survival of patients with severe congestive heart failure treated with oral milrinone. J Am Coll Cardiol 1986; 7:661-670.

22. Arnold JMO, Ludmer PL, Wright RF, Ganz P, Braunwald E, Colucci WS. The role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure. J Am Coll Cardiol 1986; 8:413-418.

23. Ribeiro JP, White HD, Arnold JMO, Hartley LH, Colucci WS. Chronic milrinone therapy: Different effects on maximal and submaximal metabolic and ventilatory responses to exercise. Am J Med 1986; 81:759-764.

24. Ludmer PL, Baim D, Antman E, Friedman PL, Gauthier D, Lanoue A, Colucci WS. Effect of milrinone on complex ventricular arrhythmias in patients with congestive heart failure. Am J Cardiol 1987; 59:1351-1355.

25. Ribeiro JP, Knutzen A, Rocco MB, Hartley LH, Colucci WS. Periodic breathing during exercise in severe heart failure: Reversal by milrinone or cardiac transplantation. Chest 1987; 92:555-556.

26. Nabel EG, Colucci WS, Lilly LS, Cutler S, Masue J, St. John Sutton MG, Dzau V, Creager M. Relationship of cardiac chamber volume to baroreflex activity in normal humans. J Clin Endo Metabol 1987; 65:475-481.

27. Colucci WS, Leatherman GF, Ludmer PL, Gauthier DF. Beta-adrenergic inotropic responsiveness of patients with heart failure: Studies with intracoronary dobutamine infusion. Circ Res 1987; 61(Suppl):I-82-I-86.

28. Colucci WS, Denniss AR, Leatherman GF, Quigg RJ, Ludmer PL, Gauthier DF. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure: Dose-response relationships, correlation with circulation catecholamines, and effect of phosphodiesterase inhibition. J Clin Invest 1988; 82:1103-1110.

29. Creager MA, Hirsch AT, Nabel EG, Cutler SS, Colucci WS, Dzau VJ. Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure. J Am Coll Cardiol 1988; 11:1191-1198.

30. Saul JP, Arai Y, Berger RQ, Lilly LS, Colucci WS, Cohen RJ. Altered autonomic regulation in chronic congestive heart failure: Assessment by heart rate spectral analysis. Am J Cardiol 1988; 61:1292-1299.

31. Colucci WS. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? J Am Coll Cardiol 1988; 12:566-569.

32. Arai Y, Saul JP, Albrecht P, Hartley LH, Lilly LS, Cohen RJ, Colucci WS. Modulation of cardiac autonomic activity during and immediately after exercise. Am J Physiol 1989; 256:H132-H141.

33. Denniss AR, Marsh JD, Quigg JR, Gordon JB, Colucci WS. Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and failing human heart. Circulation 1989; 79:1028-1034.

34. Colucci WS, Ribeiro JP, Rocco MB, Quigg RJ, Creager MA, Marsh JD, Gauthier DF, Hartley LH. Impaired chronotropic response to exercise in patients with congestive heart failure: Role of post-synaptic beta-adrenergic desensitization. Circulation 1989; 80:314-323.

35. Quigg RJ, Rocco MB, Gauthier DF, Creager MA, Hartley LH, Colucci WS. Mechanism of the attenuated maximal heart rate response to exercise following orthotopic cardiac transplantation. J Am Coll Cardiol 1989; 14:338-344.

36. Denniss RA, Colucci WS, Allen PD, Marsh JD. Distribution and function of human ventricular beta-adrenergic receptors in congestive heart failure. J Mol Cell Cardiol 1989; 21:651-660.

37. Leatherman GL, Shook TL, Leatherman SM, Colucci WS. Use of a conductance catheter to detect left ventricular inotropic state by end-systolic pressure-volume analysis. Basic Res Cardiol 1989; 84(Suppl I):247-256.

38. Creager MA, Hirsch AT, Dzau VJ, Nabel, EG, Cutler SS, Colucci WS. The contribution of baroreceptors to regional blood flow regulation in patients with congestive heart failure. Am J Physiol 1990; 27:H1409-H1414.

39. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, St. John Sutton MG, Selwyn AP, Alexander RW, Ganz P. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990; 81:772-779.

40. Arnold JMO, Ribiero JP, Colucci WS. Muscle blood flow during forearm exercise in severe heart failure. Circulation 1990; 82:465-472.

41. Colucci WS. In vivo studies of myocardial adrenergic receptor pharmacology in patients with congestive heart failure. Circulation 1990; 82:465-472.

42. Creager MA, Quigg RJ, Ren C, Roddy MA, Colucci WS. Limb vascular responsiveness to *-adrenoreceptor stimulation in patients with congestive heart failure. Circulation 1991; 83:1873-1879.

43. Parker JD, Landzberg JS, Bittl JA, Mirsky I, Colucci WS. The effects of *-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle. Circulation 1991; 84:1040-1048.

44. Landzberg JS, Parker JD, Gauthier DF, Colucci WS. Alpha-1 adrenergic receptor stimulation increases contractility in man. Circulation 1991; 84:1608-1614.

45. Colucci WS. In situ assessment of *- and *-Adrenergic responses in failing human myocardium. Circulation 1993; 87(Suppl VII):63-67.

46. Packer M, Narahara KA, Elkayam U, Sullivan JM, Pearle DL, Massie BM, Creager MA, and the Principal Investigators of the Reflect Study. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. J Am Coll Cardiol 1993; 22:65-72.

47. Colucci WS, Sonnenblick EH, Adams KF, Berk M, Brozena SC, Cowley AJ, Grabicki JM, Kubo S, LeJemtel T, Littler WA, Shabetai R, Shannon J, Starling M, Touchon RC, Wasserman AG, and the Milrinone Multicenter Trials Investigators. Chronic efficacy trials of oral milrinone in combination with converting enzyme inhibitors in patients with moderate congestive heart failure. J Am Coll Cardiol 1993; 22 (Suppl A):113A-118A.

48. Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix GH, Powers ER, Bain RP, White BH, for the Vesnarinone Study Group. Effects of vesnarinone on morbidity and mortality in patients with heart failure. N Engl J Med 1993; 329:149-155.

49. Landzberg JS, Parker JD, Gauthier DF, Colucci WS. Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation 1994; 89:164-168.

50. Loh E, Stamler JS, Hare JM, Lee TR, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994; 90:2780-2785.

51. Hare JM, Keaney JF Jr, Balligand J-L, Kelly RA, Loscalzo J, Smith TW, Colucci WS. Role of nitric oxide in autonomic control of myocardial contractility in normal dogs. Inhibition of nitric oxide synthase attenuates the parasympathetic antagonism of sympathetic inotropic response. J Clin Invest 1995; 95:360-366.

52. Loh E, Barnett JV, Couper GS, Colucci WS, Galper JB. Decreased level of Gs and adenylate cyclase activity in human myocardium following orthotopic cardiac transplantation. Circ Res 1995; 76:852-860.

53. Parker JD, Newton GE, Landzberg JS, Floras JS, Colucci WS. *-adrenergic receptor blockade: Effects on left ventricular performance and cardiac norepinephrine production. Circulation 1995; 92:1793-1800.

54. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995; 92:2198-2203.

55. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, for the US Carvedilol Heart Failure Study Group. Effect of carvedilol on morbidity and mortality in chronic heart failure. N Eng J Med 1996; 334:1349-1355.

56. Colucci, WS. Apoptosis in the heart. N Eng J Med 1996; 335:1224-1226.

57. Colucci WS. Myocardial Endothelin. Does it play a role in heart failure? Circulation 1996; 93:1069-1072.

58. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA for the U.S. Carvedilol Heart Failure Study Group. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 1996; 94; 2800-2806.

59. Packer M, Colucci WS, Sackner-Bernstein JD, Liang C, Goldscher DA, Freeman I, Kukin ML, Kinhal V, Udelson JE, Klapholz M, Gottlieb SS, Pearle D, Cody RJ, Gregory JJ, Kantrowitz N, LeJemtel TH, Young ST, Lukas MA, Shusterman NH, and the Precise Study Group. Double-blind, placebo-controlled, multicenter evaluation of the clinical effects of carvedilol in patients with moderate-to-severe heart failure. Circulation 1996; 94; 2793-2799.

60. Keaney JF Jr, Hare JM, Balligand J-L, Kelly RA, Smith TW, Colucci WS. Inhibition of nitric oxide synthase augments myocardial contractile responses to b-adrenergic stimulation. Am J Physiology 1996; 271; H2646-2652.

61. Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS. Effect of bolus miltinone on hemodynamics and pulmonary vascular resistance in patients with severe left ventricular dysfunction: A rapid test for the reversibility of pulmonary hypertension. J Am Coll Cardiol 1996; 28; 1775-1780.

62. Newton GE, Landzberg JS, Schofield AM, Colucci WS, Parker JD. Effect of intracoronary acetylcholine and atropine on basal and b-adrenergic stimulated contractility and isovolumic relaxation in the human heart. J Clin Invest 1996; 98: 2756-2763.

63. Cohn JN, Bristow MR, Chien KR, Colucci WS, Frazier OH, Leinwand LA, Lorell BH, Moss AJ, Sonnenblick EH, Walsh RA, Reinlib LJ. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 1997; 95: 766-770.

64. Hare JM, Sherman SK, Body SC, Graydon E, Colucci WS, Couper GS. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance: Evidence against a negative inotropic effect. Circulation 1997; 95: 2250-2253.

65. Givertz MM, Hartley LH, Colucci WS. Long term sequential changes in exercise capacity and chronotropic responsiveness after cardiac transplantation. Circulation 1997; 96: 232 -237.

66. Cohn JN, fowler MB, Bristow MR, colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA. Safety and efficay of carvedilol in severe heart falure. The U.S. Carvedilol Heart Failure Study Group. J Cardiac Failure 1997; 3: 173-179.

67. Hare JM, Givertz MM, Creager MA, Colucci WS. Increased sensitivity to nitric oxide inhibition in patients with heart failure: Potentiation of b-adrenergic inotropic responsiveness. Circulation 1998; 97: 161-166.

68. Communal C, Singh K, Pimentel D, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the b-adrenergic pathway. Circulation 1998; 98:1329-1334.

69. Givertz MM, Colucci, WS. New targets for heart failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet 1998; 352 (suppl. I): 34-38.

70. Eberli FR, Sam F, Ngoy S, Apstein CS, Colucci WS. Left ventricular structural and functional remodeling in the mouse after myocardial infarction: Assessment with the isovolumetrically-contracting Langendorff heart. J Mol Cell Cardiol. 1998 30:1443-7.

71. Lo MW, Toh J, Emmert SE, Ritter MA, Furtek CI, Lu H, Colucci WS, Uretsky BF, Rucinska E. Pharmacokinetics of intravenous and oral losartan in patients with heart failure. J Clin Pharmacol 1998; 38: 525-532.

72. Sam F, Sawyer DB, Chang, DLF, Eberli FR, Ngoy S, Jain M, Amin J, Apstein C, Colucci, WS. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 2000; 279:422-428.

73. Givertz MM, Colucci WS, LeJemtel TH, Gottlieb SS, Hare JM, Slawsky MT, Leier CV, Loh E, Nicklas JM, Lewis BE; on Behalf of the Study Investigators. Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation 2000; 101:2922-2927.

74. Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, Communal C, Singh K, Colucci W, Bristow MR, Port JD. Myocardial-directed overexpression of the human b1 -adrenergic receptor in transgenic mice. J Mol Cell Cardiol. 2000; 32:817-830. 75. Sawyer DA, Colucci WS. Mitochondrial oxidative stress in heart failure "oxygen wastage" Revisited. Circ Res. 2000; 86:119-120.

75. Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, Wagoner LE, Givertz MM, Liang C, Neibaur M, Haught WH, and LeJemtel TH, for the Nesiritide Study Group. Intravenous Nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. New Engl J Med 2000; 343;246-253.

76. Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 2000;102:2222-2227.

77. Cuffe MS, Califf RM, Adams KF, Bourge RC, Colucci W, Massie B, O'ConnorCM, Pina I, Quigg R, Silver M, Robinson LA, Leimberger JD, Gheorghiade M. Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. Am Heart J. 2000;139:15-22.

78. Holubarsch CJ, Colucci WS, Meinertz T, Gaus W, Tendera M. Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)-rationale, study design and study protocol. Eur J Heart Fail 2000;2(4):431-7.

79. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure. The role of the endothelium in pathophysiology and management. Circulation 2000;102:1718-1723.

80. Sanders GP, Mendes LA, Colucci WS, Givertz MM. Noninvasive methods for detecting elevated Left-sided cardiac filling pressure. Journal of Cardiac Failure 2000;6(2):157-64.

81. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, Zawadzka A, Wetzel K, Sawyer DB, Colucci WS, Apstein CS, Liao R. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 2001;103(14):1920-7.

82. Givertz MM, Sawyer DB, Colucci WS. Antioxidants and myocardial contractility illuminating the "dark-side" of b-adrenergic receptor activation. Circulation 2001;103:782-783.

83. Amin JK, Xiao L, Pimental DR, Pagano PJ, Singh K, Sawyer DB, Colucci WS. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 2001;33:131-139.

84. Givertz MM, Slawsky MT, Moraes DL, McIntyre KM, Colucci WS. Noninvasive determination of pulmonary artery wedge pressure in patients with chornic heart failure. Am J Cardiol. 2001; 87:1213-1215.

85. Loh E, Elkayam U, Cody R, Bristow M, Jaski B, Colucci WS. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure. J. Card Fail. 2001; 7(2):114-21.

86. Fowler MB, Vera-Llonch M, Oster G, Bristow MR, Cohn JN, Colucci WS, Gilbert EM, Lukas MA, Lacey MJ, Richner R, Young ST, Packer M. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group. J Am Coll Cardiol. 2001;37(6):1692-9.

87. Yancey CW, Fowler MB, Colucci WS, Gilbert EM, Bristow MR, Cohn JN, Lukas MA, Young ST, Packer M. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med 2001;344(18):1358-65.

88. Sam F, Sawyer DB, Xie Z, Chang DLF, Ngoy S, Brenner DA, Siwik DA, Singh K, Apstein CS, Colucci WS. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res 2001;89:351-356.

89. Communal C, Colucci WS, Remondino A, Sawyer, DB, Port JD, Wichman SE, Bristow MRSingh K. Reciprocal modulation of mitogen-activated protein kinases and mitogen-activatedprotein kinase phosphatase 1 and 2 in failing human myocardium. J Card Fail 2002; 8(2):86-92.

90. Maytin M and Colucci WS. Molecular and Cellular mechanisms of myocardial remodeling. J Nucl Cardiol. 2002; 9(3):319-327.

91. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K and Colucci WS. Role of oxidative stressIn myocardial hypertrophy and failure. J Mol Cell Cardiol. 2002; 34(4): 379-388.

92. Leier CV, Silver MA, Rich MW, Eichhorn EJ, Fowler MB, Giles TD, Johnstone DE, Le Jemtel TH, Lachmann JS, Levine TB, Armstrong PW, Dec WG, Jessup M, Howlett J, Hershberger RE, Cohn JN, Adams KF Jr, Colucci WS, Warner-Stevenson L, Hosenpud JD, Bristow MR, Pina I, Baughman KL, Binkley PF, Ventura HO, Francis GS, White M, Miller LW, Berry B, Missov E.Nuggets, pearls and vignettes of master heart failure clinicians. Part 4-treatment. Congest Heart Fail. 2002; 8(2): 98-124.

93. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA and Gheorghiade M. Short-term intravenous milrinone for acute exacerbation of chronic heart failure - a randomized controlled trial. JAMA 2002;287(12): 1541-1547.

Selected Review s and Chapters since 1995

1. Colucci WS. Treatment of stable heart failure: New approaches. In "Heart Failure: Cardiac Function and Dysfunction", Colucci WS (ed): In Atlas of Heart Diseases, Braunwald E (Editor-in-Chief), Philadelphia: Current Medicine, 1995.

2. Colucci WS. Pathophysiologic and clinical considerations in the treatment of heart failure: An overview. In Cardiovascular Therapeutics, Smith TW (Editor-in-Chief), Philadelphia: Saunders, Chapter 8, 1996; pp 171-175.

3. Stevenson LW, Colucci WS. Management of patients hospitalized with heart failure. In Cardiovascular Therapeutics, Smith TW (Editor-in-Chief), Philadelphia: Saunders, Chapter 10, 1996; pp 199-209.

4. Colucci WS. Principles and practice of inotropic therapy. In: Messerli FH, ed. Cardiovascular Drug Therapy, 2nd Edition, Philadelphia: WB Saunders Co., Chapter 126, 1996; pp 1146-1150.

5. Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 1997; 80: 15L-25L.

6. Colucci WS, Schoen FJ, Braunwald E. Primary tumors of the heart. In: Braunwald E, ed. Heart Disease, 5th Edition, Philadelphia: WB Saunders Co., Chapter 42, 1997; pp 1464-1477.

7. Colucci WS, Braunwald E. Pathophysiology of heart failure. In: Braunwald E, ed. Heart Disease, 5th Edition, Philadelphia: WB Saunders Co., Chapter 13,1997; pp 394-420.

8. Braunwald E, Colucci WS, Grossman W. Clinical aspects of heart failure. In: Braunwald E,ed. Heart Disease, 5th Edition, Philadelphia: WB Saunders Co., Chapter 15, 1997; pp 445-470.

9. Colucci WS, Braunwald E. Cardiac tumors, cardiac manifestations of systemic diseases, and traumatic cardiac injury. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. Harrison's Principles of Internal Medicine, 14th Edition, New York: McGraw-Hill, Chapter 241, 1997; pp 1341-1344.

10. Givertz MM, Colucci WS. Inotropic and vasoactive agents in the cardiac intensive care unit. In: Brown DL, ed. Cardiac Intensive Care, Philadelphia: WB Saunders Co., Chapter 45, 1998; pp. 545-554.

11. Ooi H and Colucci WS. Congestive Heart Failure. IN: Rakel & Bope: Conn's Current Therapy

12. Colucci WS and Braunwald E. Pathophysiology of Heart Failure. In: Braunwald E (ed): Heart Disease. 6th Edition, Philadelphia: WB Saunders Co.: 2001; (Chapter 16): 503-533.

1. Colucci WS (Editor). "Heart Failure: Cardiac Function and Dysfunction": In Atlas of Heart Diseases, Braunwald E (Editor-in-Chief), Philadelphia: Current Medicine, 1995.

2. Colucci WS (Section Editor): "Heart Failure". In Cardiovascular Therapeutics, Smith TW (Editor-in-Chief) Philadelphia: Saunders, 1996.

3. Poole-Wilson PA, Colucci WS, Chatterjee K, Coats AJS, Massie BM (Editors). Heart Failure, New York: Churchill Livingstone, 1997.
4. Colucci WS (Editor). "Heart Failure: Cardiac Function and Dysfunction": In Atlas of Heart Diseases, Second Edition, Braunwald E (Editor-in-Chief), Philadelphia: Current Medicine, 1999